EXPRESS+

It is important to understand whether a patient is feeling better and whether their health is improving as they go through treatment for methamphetamine use disorder. This is especially important in people living with HIV impacted by meth use. This study uses a behavioral treatment called “contingency management”, which motivates and rewards quitting meth. This study will look also at immune markers in the blood to see how the immune system reacts to treatment.

Need additional information?

Please indicate if you heard about us by any of these means: